AVEO Oncology (AVEO) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Oncology (NASDAQ: AVEO) reported Q1 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $20.9 million versus the consensus estimate of $20.65 million.
GUIDANCE:
AVEO Oncology sees FY2022 revenue of $100-110 million.
For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- Bank Of Marin Bancorp (BMRC) Tops Q3 EPS by 5c
- Medifast (MED) Tops Q3 EPS by 43c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
